Matthew P Confer, Kianoush Falahkheirkhah, Subin Surendran, Sumsum P Sunny, Kevin Yeh, Yen-Ting Liu, Ishaan Sharma, Andres C Orr, Isabella Lebovic, William J Magner, Sandra Lynn Sigurdson, Alfredo Aguirre, Michael R Markiewicz, Amritha Suresh, Wesley L Hicks, Praveen Birur, Moni Abraham Kuriakose, Rohit Bhargava
Oral potentially malignant disorders (OPMDs) are precursors to over 80% of oral cancers. Hematoxylin and eosin (H&E) staining, followed by pathologist interpretation of tissue and cellular morphology, is the current gold standard for diagnosis. However, this method is qualitative, can result in errors during the multi-step diagnostic process, and results may have significant inter-observer variability. Chemical imaging (CI) offers a promising alternative, wherein label-free imaging is used to record both the morphology and the composition of tissue and artificial intelligence (AI) is used to objectively assign histologic information...
March 13, 2024: Journal of Personalized Medicine